Lenvatinib 4mg Tablet
Prescription Required
Product introduction
Lenvatinib 4mg Tablet is an oral receptor tyrosine kinase inhibitor used in the treatment of thyroid cancer.
Lenvatinib 4mg Tablet is used to treat different types of cancer
Lenvatinib 4mg Tablet is used to treat different types of cancer
Uses of Lenvatinib Tablet
Benefits of Lenvatinib Tablet
In Thyroid cancer
Thyroid is a butterfly-shaped gland located at the base of your neck. Your thyroid produces hormones that regulate your heart rate, blood pressure, body temperature and weight. Thyroid cancer occurs in the cells of the thyroid and it might not cause any symptoms at first. Lenvatinib 4mg Tablet restricts the oxygen supply of the cancer cells and stops its growth as well as further spread. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side effects of Lenvatinib Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Lenvatinib
- Bleeding
- Cough
- Decreased appetite
- Erythema (skin redness)
- Hoarseness of voice
- Itching
- Joint pain
- Mouth sore
- Muscle pain
- Nausea
- Peripheral edema
- Rash
- Skin peeling
- Stomach pain
- Tiredness
- Vomiting
- Weight loss
How to use Lenvatinib Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lenvatinib 4mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Lenvatinib Tablet works
Lenvatinib 4mg Tablet is a tyrosine kinase inhibitor. It works by blocking the oxygen and nutrient supply to cancer cells due to which they stop growing.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Lenvatinib 4mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Lenvatinib 4mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Lenvatinib 4mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Lenvatinib 4mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CAUTION
Lenvatinib 4mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Lenvatinib 4mg Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Lenvatinib 4mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Lenvatinib 4mg Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Lenvatinib 4mg Tablet
βΉ159.5/Tablet
Lenvanib 4mg Tablet
AMPS Biotech Pvt Ltd
βΉ171.5/tablet
8% costlier
Quick tips
- Lenvatinib 4mg Tablet is used for the treatment of thyroid cancer.
- Take it with or without food, preferably at the same time each day.
- Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
- Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, confusion, problems with your eyesight, nausea or vomiting.
- It may cause serious bleeding problem. Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
- Do not take this medicine if you are pregnant, planning to conceive or breastfeeding.
Fact Box
Chemical Class
Quinoline Carboxamides
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Lenvima (Lenvatinib Capsules); 2019. [Accessed 05 Feb. 2020] (online) Available from:
- Lenvatinib [Prescribing Information]. Woodcliff Lake, NJ: Eisai Inc.; 2019. [Accessed 05 Feb. 2020] (online) Available from:
Marketer details
Name: Hetero Healthcare Limited
Address: S.no: 80-84, Melange towers, PatrikaNagar,Madhapur,Hyderabad. Telangana-500081.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
βΉ1595
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT